05/26/2026
You were told these drugs would transform your health.
Lose weight… lower your blood sugar… protect your heart…
That’s the promise behind today’s blockbuster GLP-1 drugs.
But what they don’t tell you?
There may be a hidden cost… one that hits where it matters most.
New research suggests these popular injections could quietly increase your risk of erectile dysfunction.
Here’s what you need to know…
In a large real-world analysis using U.S. electronic health records, researchers tracked men with type 2 diabetes for nearly three years.
They compared those starting GLP-1 drugs to those using another class of diabetes meds.
And what they found raised eyebrows…
Men taking GLP-1 drugs were 26% more likely to be diagnosed with erectile dysfunction.
But here’s the bigger issue…
This isn’t happening in a vacuum.
We already know erectile dysfunction affects nearly HALF of men with type 2 diabetes.
This is because the disease damages blood vessels… disrupts nitric oxide (your body’s key “erection signal”)… and impairs nerve function.
Now add a powerful metabolic drug into the mix…
And you have to ask:
Is it helping… or complicating the problem?
Even the researchers admit the relationship is “complex.”
Some earlier trials hinted these drugs might actually help erectile function.
Others—like this one—suggest the opposite.
And more real-world data shows increased use of ED drugs like sildenafil among men taking GLP-1s.
That’s a red flag you can’t ignore. Because it points to something patients are experiencing in the real world— not just what shows up in tightly controlled trials.
And here’s what really frustrates me…
You’re rarely told about these trade-offs up front.
So what should you do?
First, don’t panic.
This study doesn’t prove cause and effect—but it DOES raise an important question you deserve to ask.
If you’re taking a GLP-1 drug and notice changes in sexual function… don’t ignore it.
Talk to your doctor about your concerns.
And more importantly…
Start focusing on the ROOT causes of both diabetes and erectile dysfunction:
Blood sugar control
Inflammation
Circulation
Hormonal balance
Because no injection can replace fixing those fundamentals.
Source:
Chen, Y., et al. (2026). Association between glucagon-like peptide-1 receptor agonist use and risk of erectile dysfunction in men with type 2 diabetes: A target trial emulation study. eClinicalMedicine.
DOI Not Found 10.1016/j.eclinm.2026.00104-5 This DOI cannot be found in the DOI System. Possible reasons are: The DOI is incorrect in your source. Search for the item by name, title, or other metadata using a search engine. The DOI was copied incorrectly. Check to see that the string includes all th...